← Back to Manufacturing

In-Vitro Diagnostic Substance Manufacturing

Industry Overview

Stock Screener

Select filters to narrow down the 3 companies below

3 companies
$0B >$1T

Ratio between share price and earnings per share. A low ratio could indicate undervaluation.

<0 >50

Ratio of dividends in the last 12 months to current share price.

0% 3%

Revenue increase compared to the same quarter one year ago.

0% 30%

Net income increase compared to the same quarter one year ago.

0% 30%

Profitability of the last quarter.

<-30% >30%

A higher ratio indicates a higher risk. The ratio is difficult to compare between industries.

<0 >3

Discounted cash flow valuation vs. current price. Positive = undervalued, negative = overvalued.

<-50% >+100%
Market Cap
Dividends Ratio of dividends in the last 12 months to current share price
P/E Ratio
Revenue Revenue of the last quarter YoY Change
Net income Net income of the last quarter YoY Change
Profit margin Profit margin of the last quarter

Riot Platforms Inc

RIOT

Riot Platforms Inc

RIOT
Market Cap $10.63B
Dividends 0.0%
P/E Ratio -11.3
Revenue $167M +3.6%
Net Income -$500M +68.9%
Profit Margin -299.3%
Employees 110
View Stock

Achieve Life Sciences Inc.

ACHV

Achieve Life Sciences Inc.

ACHV
Market Cap $497.9M
Dividends 0.0%
P/E Ratio -4.3
Revenue $0.00
Net Income -$10.2M -20.7%
Profit Margin
Employees 13
View Stock

Oncocyte Corporation

OCX

Oncocyte Corporation

OCX
Market Cap $91.52M
Dividends 0.0%
P/E Ratio -3.9
Revenue $32k -98.5%
Net Income -$4.29M -35.7%
Profit Margin -13406.3%
View Stock